These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 22475245

  • 1. The effect of tumor necrosis factor-α antagonists on arterial stiffness in rheumatoid arthritis: a literature review.
    Dulai R, Perry M, Twycross-Lewis R, Morrissey D, Atzeni F, Greenwald S.
    Semin Arthritis Rheum; 2012 Aug; 42(1):1-8. PubMed ID: 22475245
    [Abstract] [Full Text] [Related]

  • 2. Tumour necrosis factor antagonists improve disease activity but not arterial stiffness in rheumatoid arthritis.
    Van Doornum S, McColl G, Wicks IP.
    Rheumatology (Oxford); 2005 Nov; 44(11):1428-32. PubMed ID: 16076882
    [Abstract] [Full Text] [Related]

  • 3. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy.
    Mäki-Petäjä KM, Hall FC, Booth AD, Wallace SM, Yasmin, Bearcroft PW, Harish S, Furlong A, McEniery CM, Brown J, Wilkinson IB.
    Circulation; 2006 Sep 12; 114(11):1185-92. PubMed ID: 16952987
    [Abstract] [Full Text] [Related]

  • 4. The effect of TNF-a antagonists on aortic stiffness and wave reflections: a meta-analysis.
    Vlachopoulos C, Gravos A, Georgiopoulos G, Terentes-Printzios D, Ioakeimidis N, Vassilopoulos D, Stamatelopoulos K, Tousoulis D.
    Clin Rheumatol; 2018 Feb 12; 37(2):515-526. PubMed ID: 28484887
    [Abstract] [Full Text] [Related]

  • 5. No significant changes in arterial stiffness in patients with ankylosing spondylitis after tumour necrosis factor alpha blockade treatment for 6 and 12 months.
    Mathieu S, Pereira B, Couderc M, Rabois E, Dubost JJ, Soubrier M.
    Rheumatology (Oxford); 2013 Jan 12; 52(1):204-9. PubMed ID: 23065359
    [Abstract] [Full Text] [Related]

  • 6. Tumor necrosis factor-alpha antagonists improve aortic stiffness in patients with inflammatory arthropathies: a controlled study.
    Angel K, Provan SA, Gulseth HL, Mowinckel P, Kvien TK, Atar D.
    Hypertension; 2010 Feb 12; 55(2):333-8. PubMed ID: 20038753
    [Abstract] [Full Text] [Related]

  • 7. B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents.
    Finckh A, Ciurea A, Brulhart L, Kyburz D, Möller B, Dehler S, Revaz S, Dudler J, Gabay C, Physicians of the Swiss Clinical Quality Management Program for Rheumatoid Arthritis.
    Arthritis Rheum; 2007 May 12; 56(5):1417-23. PubMed ID: 17469098
    [Abstract] [Full Text] [Related]

  • 8. Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up.
    Dewedar AM, Shalaby MA, Al-Homaid S, Mahfouz AM, Shams OA, Fathy A.
    Int J Rheum Dis; 2012 Jun 12; 15(3):330-5. PubMed ID: 22709496
    [Abstract] [Full Text] [Related]

  • 9. Therapeutic agents for patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor-alpha antagonists.
    Isaacs JD.
    Expert Opin Biol Ther; 2009 Dec 12; 9(12):1463-75. PubMed ID: 19916731
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of adalimumab for rheumatoid arthritis in patients with a history of TNF-antagonist therapy in clinical practice.
    Bombardieri S, Ruiz AA, Fardellone P, Geusens P, McKenna F, Unnebrink K, Oezer U, Kary S, Kupper H, Burmester GR, Research in Active Rheumatoid Arthritis (ReAct) Study Group.
    Rheumatology (Oxford); 2007 Jul 12; 46(7):1191-9. PubMed ID: 17504821
    [Abstract] [Full Text] [Related]

  • 11. Etanercept normalises left ventricular mass in patients with rheumatoid arthritis.
    Daïen CI, Fesler P, du Cailar G, Daïen V, Mura T, Dupuy AM, Cristol JP, Ribstein J, Combe B, Morel J.
    Ann Rheum Dis; 2013 Jun 12; 72(6):881-7. PubMed ID: 22872022
    [Abstract] [Full Text] [Related]

  • 12. Effects of biologics on vascular function and atherosclerosis associated with rheumatoid arthritis.
    Kerekes G, Soltész P, Dér H, Veres K, Szabó Z, Végvári A, Shoenfeld Y, Szekanecz Z.
    Ann N Y Acad Sci; 2009 Sep 12; 1173():814-21. PubMed ID: 19758233
    [Abstract] [Full Text] [Related]

  • 13. [TNF antagonists in therapy of rheumatoid arthritis].
    Oberpichler-Schwenk H.
    Med Monatsschr Pharm; 1999 Nov 12; 22(11):334-9. PubMed ID: 10596266
    [No Abstract] [Full Text] [Related]

  • 14. Can suppression of inflammation by anti-TNF prevent progression of subclinical atherosclerosis in inflammatory arthritis?
    Tam LS, Kitas GD, González-Gay MA.
    Rheumatology (Oxford); 2014 Jun 12; 53(6):1108-19. PubMed ID: 24501245
    [Abstract] [Full Text] [Related]

  • 15. Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-alpha blockers: the GISEA study.
    Mancarella L, Bobbio-Pallavicini F, Ceccarelli F, Falappone PC, Ferrante A, Malesci D, Massara A, Nacci F, Secchi ME, Manganelli S, Salaffi F, Bambara ML, Bombardieri S, Cutolo M, Ferri C, Galeazzi M, Gerli R, Giacomelli R, Grassi W, Lapadula G, Cerinic MM, Montecucco C, Trotta F, Triolo G, Valentini G, Valesini G, Ferraccioli GF, GISEA group.
    J Rheumatol; 2007 Aug 12; 34(8):1670-3. PubMed ID: 17611987
    [Abstract] [Full Text] [Related]

  • 16. TNF-alpha, rheumatoid arthritis, and heart failure: a rheumatological dilemma.
    Sarzi-Puttini P, Atzeni F, Shoenfeld Y, Ferraccioli G.
    Autoimmun Rev; 2005 Mar 12; 4(3):153-61. PubMed ID: 15823501
    [Abstract] [Full Text] [Related]

  • 17. Differentiating the efficacy of tumor necrosis factor inhibitors.
    Haraoui B.
    J Rheumatol Suppl; 2005 Mar 12; 74():3-7. PubMed ID: 15742457
    [Abstract] [Full Text] [Related]

  • 18. Infliximab improves vascular stiffness in patients with rheumatoid arthritis.
    Wong M, Oakley SP, Young L, Jiang BY, Wierzbicki A, Panayi G, Chowienczyk P, Kirkham B.
    Ann Rheum Dis; 2009 Aug 12; 68(8):1277-84. PubMed ID: 18930987
    [Abstract] [Full Text] [Related]

  • 19. Clinical improvement in rheumatoid arthritis is associated with healthier microvascular function in patients who respond to antirheumatic therapy.
    Galarraga B, Belch JJ, Pullar T, Ogston S, Khan F.
    J Rheumatol; 2010 Mar 12; 37(3):521-8. PubMed ID: 20080919
    [Abstract] [Full Text] [Related]

  • 20. Etanercept improves inflammation-associated arterial stiffness in rheumatoid arthritis.
    Galarraga B, Khan F, Kumar P, Pullar T, Belch JJ.
    Rheumatology (Oxford); 2009 Nov 12; 48(11):1418-23. PubMed ID: 19734293
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.